Top Penny Stocks To Own Right Now

Over the years, a diminishing number of employers have offered pensions to their workers. Between the early 1990s and the early 2010s, pension plan availability fell roughly by half, from about one in three workers having access to a pension 25 years ago, to only one in six more recently. If you’re fortunate enough to work for an employer that gives you a chance to get pension payments when you retire, it’s important to know what you need to do in order to make the most of them. That way, when you decide to end your career, you’ll know you’ll be getting every penny available to you to last you the rest of your life.

Although pension income is a valuable retirement benefit that can supplement your Social Security benefits and make your retirement a lot more financially secure, it also comes with some extra responsibilities. Your monthly pension payment almost always counts as taxable income, and you’ll need to make sure that you have enough taxes withheld from your pension payments to satisfy the Internal Revenue Service.

Top Penny Stocks To Own Right Now: Aerosonic Corporation(AIM)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Aimia Inc (TSE:AIM) have earned a consensus rating of “Hold” from the seven research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the company. The average 1 year price target among brokers that have covered the stock in the last year is C$3.54.

  • [By Shane Hupp]

    Aimia (TSE:AIM) has earned an average rating of “Hold” from the seven research firms that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has given a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is C$2.67.

Top Penny Stocks To Own Right Now: UFP Technologies Inc.(UFPT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    UFP Technologies (NASDAQ: UFPT) and China XD Plastics (NASDAQ:CXDC) are both small-cap industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings.

  • [By Ethan Ryder]

    Media coverage about UFP Technologies (NASDAQ:UFPT) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. UFP Technologies earned a daily sentiment score of 0.03 on Accern’s scale. Accern also assigned headlines about the industrial products company an impact score of 47.0533500754779 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Logan Wallace]

    China XD Plastics (NASDAQ: CXDC) and UFP Technologies (NASDAQ:UFPT) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.

Top Penny Stocks To Own Right Now: Safe Bulkers Inc(SB)

Advisors’ Opinion:

  • [By Rich Smith]

    Ocean-going bulk shipper Safe Bulkers (NYSE:SB) reported its fiscal Q1 2018 earnings results on Tuesday — an “earnings beat” that nudged the company’s shares up 2%. But it took until Thursday for the real good news to arrive. Today, all of the sudden, the stock jumped out of its berth and closed 12.2% higher.

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Big Lots, Inc. (NYSE: BIG) shares fell 9.6 percent to $37.01 in pre-market trading after the company reported weaker-than-expected results for its first quarter and issued downbeat earnings forecast.
    Tilly's, Inc. (NYSE: TLYS) fell 5.7 percent to $12.98 in pre-market trading after rising 12.69 percent on Thursday.
    Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) fell 4.2 percent to $6.39 in pre-market trading after dropping 4.71 percent on Thursday.
    Sunlands Online Education Group (NYSE: STG) fell 4.2 percent to $9.13 in pre-market trading.
    Safe Bulkers, Inc. (NYSE: SB) fell 4.2 percent to $3.42 in pre-market trading after climbing 12.62 percent on Thursday.
    Ulta Beauty, Inc. (NASDAQ: ULTA) fell 4.1 percent to $236.80 in pre-market trading. Ulta Beauty reported upbeat results for its first quarter, but issued weak second-quarter earnings and sales guidance.
    GameStop Corp. (NYSE: GME) shares fell 3.8 percent to $12.70 in pre-market trading. GameStop reported in-line earnings for its first quarter, while sales missed estimates.
    Workday, Inc. (NASDAQ: WDAY) fell 3.2 percent to $126.85 in the pre-market trading session after the company posted Q1 results.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 3 percent to $57.15 in pre-market trading

  • [By Ethan Ryder]

    Safe Bulkers (NYSE:SB) was downgraded by research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Tuesday.

  • [By Ethan Ryder]

    Evermore Global Advisors LLC trimmed its holdings in shares of Safe Bulkers, Inc. (NYSE:SB) by 24.1% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 1,997,101 shares of the shipping company’s stock after selling 635,851 shares during the quarter. Safe Bulkers accounts for approximately 2.2% of Evermore Global Advisors LLC’s holdings, making the stock its 14th biggest holding. Evermore Global Advisors LLC’s holdings in Safe Bulkers were worth $6,790,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Safe Bulkers alerts:

    Safe Bulkers (SB): Moving Average Crossover Alert (finance.yahoo.com) Should Investors Have Safe Bulkers, Inc. (NYSE:SB) In Their Porfolio After Profit Growth of 0.63922? (zeelandpress.com) Detailed Research: Economic Perspectives on Safe Bulkers, SITO Mobile, Castle Brands, Motorcar Parts of America … (nasdaq.com) Simple Rule To have an eye on These Stocks:- BioTime, Inc. (NYSE:BTX), Safe Bulkers, Inc. (NYSE:SB), Mettler-Toledo … (thestreetpoint.com) Safe Bulkers, Inc. (NYSE:SB): How is this stock valued? (cantoncaller.com)

    Several research firms have commented on SB. Zacks Investment Research downgraded shares of Safe Bulkers from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 1st. ValuEngine downgraded shares of Safe Bulkers from a “hold” rating to a “sell” rating in a research report on Tuesday. TheStreet raised shares of Safe Bulkers from a “d+” rating to a “c-” rating in a research report on Wednesday, June 27th. Seaport Global Securities raised shares of Safe Bulkers from a “neutral” rating to a “buy” rating and increased their target price for the stock from $3.50 to $5.00 in a research report on Tuesday, July 31st. Finally, Maxim Group reissued a “buy” rating and set a $6.00 target price on shares of Safe Bulkers in a research report on Monday, July 23rd. Three analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $3.79.

Top Penny Stocks To Own Right Now: Patni Computer Systems Limited(PTI)

Advisors’ Opinion:

  • [By Chris Lange]

    Proteostasis Therapeutics Inc. (NASDAQ: PTI) saw its shares slide early on Thursday after the company reported that it had positive data from its early stage trial in cystic fibrosis (CF). These results come from the firm’s ongoing Phase 1 dosing study of PTI-801 in CF patients on background Orkambi (lumacaftor/ivacaftor) therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *